SYNLOGIC, INC. Other Non-Current Liabilities
SYNLOGIC, INC. (SYBX) had Other Non-Current Liabilities of $131.00 thousand as of 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2022-03-17
- 2021-09-30: Other Liabilities, Noncurrent $131.00K.
- 2021-06-30: Other Liabilities, Noncurrent $131.00K.
- 2021-03-31: Other Liabilities, Noncurrent $131.00K.
- 2020-12-31: Other Liabilities, Noncurrent $131.00K.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2021-09-30 | $131.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $131.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $131.00K 10-Q · filed 2021-05-13 |
| 2020-12-31 | $131.00K 10-K · filed 2022-03-17 |
| 2020-09-30 | $176.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $82.00K 10-Q · filed 2020-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |